<DOC>
	<DOCNO>NCT01374919</DOCNO>
	<brief_summary>The aim study recruit 30 patient refer Auerach Hematology Oncology Assoc . treatment iron defeciency anemia iv iron ( Ferumoxytol 1020 mg ) administer via infusion pump 15 minute . To ascertain acute safety tolerability ferumoxytol immediate post dose observation period . Assess additional safety profile laboratory assessment follow visit interim telephone follow .</brief_summary>
	<brief_title>Total Dose Infusion Ferumoxytol ( 1020mg ) 15 Minutes Iron Deficiency Anemia</brief_title>
	<detailed_description>Ferumoxytol , modify iron dextran , allow rapid administration IV iron without free iron release , approve 510 mg injection administer less 17 second . Although represent felicitous treatment patient come frequently , dialysis chemotherapy patient , multiple publication suggest full dose replacement usually 1000 mg level . No study extant available dosing schedule ferumoxytol . In trial , iron deficient patient hemoglobin level &lt; 11.0 gram per deciliter consent received 1020 mg ( two 510 mg vial ) ferumoxytol 15 minute . Vital sign perform 5 , 10 , 15 , 30 60 minute . Followup phone call clinical adverse event make 24-48 hour one week administration . At four week follow-up hematologic serologic ( iron parameter ) make along physician visit .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferrosoferric Oxide</mesh_term>
	<criteria>Iron deficiency anemia intolerant failure respond oral iron condition oral iron know ineffective harmful . Subject must able contacted 2448 hour dose come followup four week . Subject must capable understanding inform consent No form iron may take within four week consent four week treatment History hypersensitivity ferumoxytol . Imminent dialysis . Anemia due etiology . Parenteral iron within 4 week consent . Pregnancy . Erythropoiesis stimulate agent within 30 day consent . Other illness would interfere participation understand trial . Major surgery plan within four week consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Intravenous iron</keyword>
	<keyword>ferumoxytol</keyword>
	<keyword>iron deficiency anemia</keyword>
	<keyword>Treatment iron deficiency</keyword>
	<keyword>Intolerance ineffectiveness oral iron</keyword>
</DOC>